Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of streptococcus pneumoniae in patients with acute exacerbation of chronic bronchitis.

Trial Profile

An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of streptococcus pneumoniae in patients with acute exacerbation of chronic bronchitis.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Telithromycin (Primary) ; Azithromycin; Cefuroxime
  • Indications Acute exacerbations of chronic bronchitis; Streptococcal infections
  • Focus Therapeutic Use
  • Acronyms PERSPECTIVE
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2011 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
    • 17 Oct 2006 Status change
    • 13 Jan 2006 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top